Hydroxyproline metabolism in mice contributes significantly to oxalate synthesis.

The contribution is greater in Agxt and Grhpr KO mice than in wild type mice.

Decreasing hepatic GO and HYPDH expression decreases oxalate excretion.

RNAi therapeutics could be helpful in treating Primary Hyperoxaluria.